logo
Paycom Software, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call

Paycom Software, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call

Business Wire16-07-2025
OKLAHOMA CITY--(BUSINESS WIRE)-- Paycom Software, Inc. ('Paycom') (NYSE: PAYC), a leading provider of comprehensive, cloud-based human capital management software, will release its results for the second quarter ended Jun. 30, 2025, after the market closes on Aug. 6. Paycom will also hold a conference call to discuss results at 5 p.m. (Eastern) that day.
The conference call will also be webcast at investors.paycom.com. For those unable to participate, a replay will be available following the conclusion of the earnings call on Aug. 6 through Aug. 13. A web-based archive of the conference call will also be available at the above website.
About Paycom
For over 25 years, Paycom Software, Inc. (NYSE: PAYC) has simplified business and employees' lives through easy-to-use HR and payroll technology to empower transparency through direct access to their data. From onboarding and benefits enrollment to talent management and more, Paycom's employee-first technology leverages full-solution automation to streamline processes, drive efficiencies and give employees power over their own HR information, all in a single app. Paycom's single database combines all HR and payroll data in one place, providing a seamless and accurate experience without the errors and inefficiencies associated with integrating multiple systems. Recognized globally for its technology and workplace culture, Paycom serves businesses of all sizes in the U.S. and internationally.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ...
Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ...

Yahoo

time19 minutes ago

  • Yahoo

Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ...

Revenue: $720 million in Q2, 3% organic growth. Adjusted EPS: $1.18, above expectations. Life Sciences Segment Growth: 4% organic growth. Diagnostics Segment Growth: 2% organic growth. Signals Software Growth: Over 30% organic growth. Free Cash Flow: $115 million in Q2, 83% conversion of adjusted net income. Operating Margin: 26.6% adjusted operating margin, down 210 basis points year over year. Share Repurchase: $293 million worth of shares repurchased in Q2. Full-Year Organic Growth Outlook: 2% to 4% range. Full-Year Adjusted EPS Outlook: $4.85 to $4.95. Net-Debt-to-Adjusted-EBITDA Ratio: 2.6 times. Adjusted Tax Rate: 19.1% in Q2. Warning! GuruFocus has detected 5 Warning Signs with RVTY. Release Date: July 28, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Revvity Inc (NYSE:RVTY) achieved 3% organic growth in Q2 2025, in line with expectations, driven by strong performance in the Life Sciences segment. The Signals Software franchise experienced approximately 30% growth, setting a new record for orders in a single quarter. Revvity Inc (NYSE:RVTY) reported adjusted EPS of $1.18, which was above expectations and guidance. The company generated $115 million in free cash flow during the quarter, maintaining a solid 90% conversion rate year-to-date. Revvity Inc (NYSE:RVTY) repurchased nearly $300 million worth of stock in Q2, bringing total repurchases to nearly $450 million for the first half of the year. Negative Points The Diagnostics segment faced challenges in China due to changes in hospital lab reimbursement policies, impacting the Immunodiagnostics business. Revvity Inc (NYSE:RVTY) lowered its full-year organic growth outlook to 2% to 4%, down 1% from prior expectations. The company anticipates a meaningful pullback in its Immunodiagnostics business in China for the remainder of the year. Operating margins were pressured by lower volumes of high-margin diagnostic tests and recent changes in FX rates. The academic and government customer segment continued to show weakness, with revenue declining in the low single digits year over year. Q & A Highlights Q: Can you explain the guidance change related to organic growth, particularly in China, and whether other factors like VBP are involved? A: (Prahlad Singh, CEO) The majority of the impact is from the DRG policy in China, which affects multiplex tests. This policy reduces test volumes, but in the long term, it may lead to more single-plex tests, which are more expensive. We are working with stakeholders to potentially reverse these changes due to their impact on patient care. Q: Regarding margin changes, what are your expectations for 2026 margins, and what growth assumptions are they based on? A: (Maxwell Krakowiak, CFO) We expect a baseline operating margin of 28% for 2026, with margin expansion depending on organic growth levels. Typically, with high single-digit growth, we expect a 75 basis point margin expansion, and with mid-single-digit growth, about 50 basis points. Q: What are the revenue pacing assumptions for this year, and how do you see the impact of NIH funding and year-end budget flush? A: (Maxwell Krakowiak, CFO) We expect normal seasonality with a high single-digit ramp in both Life Sciences and Diagnostics. The fourth quarter will see a ramp-up in gel and larger volume in Signals Software. We assume academic and government funding will remain weak for the rest of the year. Q: Can you provide insights into the Life Sciences segment's performance, particularly reagents and instruments, and any guidance changes? A: (Prahlad Singh, CEO) Pharma-biotech showed stability with mid-single-digit growth, and our Life Sciences reagents business has grown for five consecutive quarters. While capital equipment spending is impacted, we remain optimistic about the reagents business. Q: How is the Software segment performing, and what are the expectations for growth in the second half? A: (Prahlad Singh, CEO) The Signals Software business had a record quarter with 32% organic growth. We focus on net retention, ARR, and APV, with strong SaaS bookings. We expect continued growth due to investments and new product launches. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

PCI Pal Launches Fraud Management Suite to Strengthen Contact Center Security
PCI Pal Launches Fraud Management Suite to Strengthen Contact Center Security

Business Wire

time20 minutes ago

  • Business Wire

PCI Pal Launches Fraud Management Suite to Strengthen Contact Center Security

CHARLOTTE, N.C.--(BUSINESS WIRE)--PCI Pal ® (LON: PCIP) today announced the launch of its new Fraud Management Suite, beginning with AI-powered risk scoring for customer engagements. Designed to protect against rising card-not-present (CNP) fraud, the new capability delivers real-time risk insights to agents and AI bots before a payment is collected — reducing chargebacks and revenue loss without adding friction to the customer experience. 'AI is transforming how we approach security — not just in detecting fraud, but in anticipating it." Share CNP fraud remains one of the most costly threats for global businesses. While e-commerce channels benefit from tools like 3D Secure and biometric authentication, the voice channel — still central to many contact centers — has lacked equivalent protection. PCI Pal is closing that gap with a platform-led approach that combines security, compliance, and usability. 'This is the first step in a multi-product journey to deliver continuous value to our customers and partners,' said Alessandro Dalla Volta, VP of Product at PCI Pal. 'By embedding risk scoring into our Secure Payments Suite via an intuitive agent interface and a single API, we're giving contact centers powerful tools to detect fraud early and authenticate their customers seamlessly — across agents and bots using digital channels as needed.' A Smarter Way to Fight Fraud The new Fraud Management Suite helps organizations respond to evolving threats with: Real-time AI-powered risk scoring leveraging technology for early fraud detection in partnership with Telesign, a Proximus Global company Adaptive authentication, including 3D Secure and biometric wallet support Advanced analytics and chargeback defense tools Built for the Modern Contact Center 'AI is transforming how we approach security — not just in detecting fraud, but in anticipating it,' said Mufti Monim, CTO of PCI Pal. 'This launch lays the groundwork for a more intelligent and adaptive platform, that secures payments across all channels while enhancing both customer and agent experiences. It's the first step in a broader roadmap to unify fraud prevention, compliance, and customer experience into one seamless, scalable platform.' Availability AI-powered risk scoring is now available as part of the PCI Pal platform. Learn more at About PCI Pal PCI Pal ® (LON: PCIP) is a leading provider of secure payment solutions for business communications. PCI Pal's mission is to safeguard reputations and trust by securing payments wherever customer engagement occurs. With its patented, cloud-based platform, PCI Pal enables organizations to take secure payments via voice, chat, email, and social, while ensuring compliance with industry standards such as PCI DSS. For more information, visit

Walmart Stock (WMT) Widening Gap on Rivals Despite Holiday Price Hikes Ahead
Walmart Stock (WMT) Widening Gap on Rivals Despite Holiday Price Hikes Ahead

Business Insider

timean hour ago

  • Business Insider

Walmart Stock (WMT) Widening Gap on Rivals Despite Holiday Price Hikes Ahead

Shares in U.S. retail giant Walmart (WMT) were marked higher today as it said it expects to gain market share from tariff turmoil this year. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Market Share According to a note from analysts at Jefferies, even though Walmart has already raised prices on a range of goods given the uncertainty around President Trump's tariffs, it still expects to gain market share from its peers. Following a recent meeting with Walmart's head of investor relations, Steph Wissink, Jefferies said in a note that 'prices increased as the tariffs were implemented in April' for perishables and other items sourced from Central America. The firm noted that in June, prices also began to rise on 'infrequently purchased general merchandise items that were previously trending deflationary.' Such macro risks are key for consumer-facing stocks like Walmart as one can see below. Value Focus Jefferies said Walmart (NYSE:WMT) expects further increases on 'seasonal items heading into Halloween and the winter holidays,' but remains committed to its value-focused strategy: 'WMT remains committed to its Everyday Low Price strategy and taking less price than its peers,' it said. Despite inflationary pressures, Jefferies said Walmart believes that the U.S. consumer has been relatively resilient. 'We would categorize the US consumer as consistent,' said Jefferies, though Walmart has seen 'emerging signs of trade down and substitution.' It is understood that Walmart plans to aggressively compete during the upcoming back-to-school season by 'widening its price gaps on key, high-frequency items,' which it expects will boost share as consumers become more price-sensitive. Walmart is already performing well against its peers as can be seen below. In terms of inventory, Jefferies said Walmart expects it to jump in the second quarter given that the 'actual tariff rate is higher than originally expected.' However, analysts said they are 'not concerned about the health of the inventory.' Jefferies expects the company to reaffirm its full-year outlook, stating, 'We believe that WMT is well-positioned to achieve its guidance,' even as tariff-related volatility limits near-term upside. Jefferies has a Buy rating on the stock and a $120 price target. Is WMT a Good Stock to Buy Now? On TipRanks, WMT has a Strong Buy consensus based on 28 Buy ratings. Its highest price target is $120. WMT stock's consensus price target is $111.33, implying a 14.06% upside.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store